7-131108064-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NR_015431.2(LINC-PINT):n.920T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000842 in 152,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00084 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
LINC-PINT
NR_015431.2 non_coding_transcript_exon
NR_015431.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.32
Genes affected
LINC-PINT (HGNC:26885): (long intergenic non-protein coding RNA, p53 induced transcript) Predicted to act upstream of or within several processes, including adipose tissue development; adult somatic muscle development; and hair follicle development. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 7-131108064-A-C is Benign according to our data. Variant chr7-131108064-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 3052262.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LINC-PINT | NR_015431.2 | n.920T>G | non_coding_transcript_exon_variant | 2/5 | ||||
LINC-PINT | NR_109850.1 | n.920T>G | non_coding_transcript_exon_variant | 2/6 | ||||
LINC-PINT | NR_109851.1 | n.920T>G | non_coding_transcript_exon_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINC-PINT | ENST00000431189.2 | n.51T>G | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
LINC-PINT | ENST00000443623.6 | n.80T>G | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
LINC-PINT | ENST00000451786.6 | n.1180T>G | non_coding_transcript_exon_variant | 2/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000836 AC: 127AN: 151946Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
127
AN:
151946
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 54Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 40
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
54
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
40
Gnomad4 AFR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000842 AC: 128AN: 152064Hom.: 0 Cov.: 32 AF XY: 0.000861 AC XY: 64AN XY: 74326
GnomAD4 genome
AF:
AC:
128
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
64
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
LINC-PINT-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at